The Research and Development team at Lycia Therapeutics is responsible for pioneering advancements in extracellular protein degradation through the LYTAC platform. This team orchestrates the discovery, development, and validation of innovative biologics and chemical entities, ensuring their progression from early research phases to translational and nonclinical development.
View all